This is a biased opinion as I truly believe the Psychedelic stock market will be expanding more and more in the years to come. Hence my long term bullish approach. Mindmed has been in a downtrend since Q3 21. Early February, price was rejected at yearly open. I do not think this reflects the company value but rather a market sentiment. Earnings early march might give some volume.
Investment thesis is as follow: I want to support companies that are working towards a better understanding of mental health issues, but I want my support to be as efficient as possible considering the economic uncertainties that surrounds the global market.
Either price reclaim yearly open if XBI and IWM rally/bounce
Downfall across the market continues--> buying between 55-80cent/share for best r:r
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.